Despite papillary renal cell carcinoma (pRCC) subtype represents the second most common histological renal tumor, controversial findings have been shown regarding its prognosis. Thus, we investigated the natural history of patients harbouring pRCC, focusing on its clinicopathological characteristics and long-term oncologic outcomes among pRCC subtypes.
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma / Basile, Giuseppe; Rosiello, Giuseppe; Larcher, Alessandro; Fallara, Giuseppe; Martini, Alberto; Re, Chiara; Cignoli, Daniele; Tian, Zhe; Karakiewicz, Pierre I; Mottrie, Alexandre; Bertini, Roberto; Necchi, Andrea; Raggi, Daniele; Salonia, Andrea; Briganti, Alberto; Montorsi, Francesco; Capitanio, Umberto. - In: UROLOGIC ONCOLOGY. - ISSN 1078-1439. - 40:8(2022), pp. 384-384.e21. [Epub ahead of print] [10.1016/j.urolonc.2022.05.012]
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma
Basile, Giuseppe;Rosiello, Giuseppe;Larcher, Alessandro;Fallara, Giuseppe;Martini, Alberto;Re, Chiara;Cignoli, Daniele;Necchi, Andrea;Salonia, Andrea;Briganti, Alberto;Montorsi, Francesco;
2022-01-01
Abstract
Despite papillary renal cell carcinoma (pRCC) subtype represents the second most common histological renal tumor, controversial findings have been shown regarding its prognosis. Thus, we investigated the natural history of patients harbouring pRCC, focusing on its clinicopathological characteristics and long-term oncologic outcomes among pRCC subtypes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
